What will the next generation of reporting and analytics in pharmacovigilance be? Will it move the needle on business innovation…
Learn More
The Shift to the Cloud Historically, firms relied heavily on on-premises implementations for their enterprise solutions, including safety systems. Reliance…
Learn More
With up to 30-50% annual growth in adverse event cases, how are pharmacovigilance teams managing with today’s constrained budgets,…
Learn More
South Korean Contract Research Organization, LSK, spoke in a webinar with ArisGlobal to address the pressures of modernizing pharmacovigilance…
Learn More
The Future of Drug Safety Intelligence The future of safety intelligence is closer…
Learn More
There’s no doubt that the pharmaceutical industry is well into its ‘age of automation’. A…
Learn More
Over 200 Life Sciences organizations worldwide are adopting ArisGlobal’s LifeSphere Safety™ multi-tenant cloud platform to achieve E2B(R3) compliance by November 2017 EMA deadline. Within that platform, ArisGlobal’s LifeSphere Safety MultiVigilance™ solution leads the way in transforming safety case management through technology and regulatory expertise.
Learn More
Next-Generation, Multi-Tenant Cloud Solution Offers Enhanced Capabilities for the Complete Management of Safety Signals and Benefit-Risk Assessment Chicago, Illinois, June…
Learn MoreSafety departments at Marketing Authorization Holders & Regulatory Authorities are under pressure from all sides. They must constantly stay on…
Learn More
White Paper: The Evolution of Signal Detection and Management 